StockData
Stereotaxis, Inc. logo

Stereotaxis, Inc. (STXS) stock

STXSNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/3018% below fair value
$0.88+0.08 (+9.89%)

Close on Nov 17, 2026Market cap $88.39MP/E –Yield –

Stereotaxis cash

Cash and short-term investments held at the end of each period.

Stereotaxis's cash was $10.49M at Jun 30, 2026. For fiscal 2025 it was $13.42M, up 9.9% from the year before. Over ten years it grew 9.1% a year on average. The highest annual figure on record is $43.94M in fiscal 2020.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$13.42M+9.9%
FY2024Dec 31, 2024$12.22M-38.4%
FY2023Dec 31, 2023$19.82M-33.3%
FY2022Dec 31, 2022$29.70M-26.0%
FY2021Dec 31, 2021$40.14M-8.6%
FY2020Dec 31, 2020$43.94M+45.6%
FY2019Dec 31, 2019$30.18M+179.6%
FY2018Dec 31, 2018$10.80M+192.9%
FY2017Dec 31, 2017$3.69M-56.6%
FY2016Dec 31, 2016$8.50M+52.0%
FY2015Dec 31, 2015$5.59M-23.1%
FY2014Dec 31, 2014$7.27M-47.2%
FY2013Dec 31, 2013$13.78M+77.1%
FY2012Dec 31, 2012$7.78M-44.3%
FY2011Dec 31, 2011$13.95M-60.4%
FY2010Dec 31, 2010$35.25M+15.4%
FY2009Dec 31, 2009$30.55M+0.6%
FY2008Dec 31, 2008$30.36M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$10.49M+50.6%
Q1 FY2026Mar 31, 2026$14.62M+37.9%
Q4 FY2025Dec 31, 2025$13.42M+9.9%
Q3 FY2025Sep 30, 2025$10.51M-1.5%
Q2 FY2025Jun 30, 2025$6.97M-52.6%
Q1 FY2025Mar 31, 2025$10.60M-39.9%
Q4 FY2024Dec 31, 2024$12.22M-38.4%
Q3 FY2024Sep 30, 2024$10.66M-51.8%
Q2 FY2024Jun 30, 2024$14.68M-35.8%
Q1 FY2024Mar 31, 2024$17.63M-31.3%
Q4 FY2023Dec 31, 2023$19.82M-33.3%
Q3 FY2023Sep 30, 2023$22.10M-28.6%
Q2 FY2023Jun 30, 2023$22.88M-31.7%
Q1 FY2023Mar 31, 2023$25.66M-26.9%
Q4 FY2022Dec 31, 2022$29.70M-26.0%
Q3 FY2022Sep 30, 2022$30.94M-23.1%
Q2 FY2022Jun 30, 2022$33.50M-20.3%
Q1 FY2022Mar 31, 2022$35.10M-17.3%
Q4 FY2021Dec 31, 2021$40.14M-8.6%
Q3 FY2021Sep 30, 2021$40.24M-7.7%
Q2 FY2021Jun 30, 2021$42.05M-4.4%
Q1 FY2021Mar 31, 2021$42.45M+51.5%
Q4 FY2020Dec 31, 2020$43.94M+45.6%
Q3 FY2020Sep 30, 2020$43.60M+37.7%
Q2 FY2020Jun 30, 2020$44.01M+419.4%
Q1 FY2020Mar 31, 2020$28.02M+210.0%
Q4 FY2019Dec 31, 2019$30.18M+179.6%
Q3 FY2019Sep 30, 2019$31.65M+173.5%
Q2 FY2019Jun 30, 2019$8.47M-29.4%
Q1 FY2019Mar 31, 2019$9.04M-22.2%
Q4 FY2018Dec 31, 2018$10.80M+192.9%
Q3 FY2018Sep 30, 2018$11.57M+157.9%
Q2 FY2018Jun 30, 2018$11.99M+138.1%
Q1 FY2018Mar 31, 2018$11.61M+102.4%
Q4 FY2017Dec 31, 2017$3.69M-56.6%
Q3 FY2017Sep 30, 2017$4.49M-51.5%
Q2 FY2017Jun 30, 2017$5.04M–
Q1 FY2017Mar 31, 2017$5.74M–
Q4 FY2016Dec 31, 2016$8.50M–
Q3 FY2016Sep 30, 2016$9.24M–

More Stereotaxis figures

See a number that looks wrong?